Related Experiment Video

Updated: Sep 20, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

674

Targeting lipid metabolism in cancer: neuroblastoma

Massimiliano Agostini1, Gerry Melino2, Bola Habeb3

  • 1Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy. nbazan@lsuhsc.edu.

Cancer Metastasis Reviews
|June 10, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ELOVL4 transcriptionElovanoidsFatty acid oxidationFatty acid synthesisMYCVery-long-chain polyunsaturated fatty acids

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.1K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K

Related Experiment Videos

Last Updated: Sep 20, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

674
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.1K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

SERPINH1 expression represents a reliable biomarker of human breast cancer aggressiveness.

Biology direct·2026

Thyrotoxic periodic paralysis presenting with severe hypokalaemia and cardiac involvement.

BMJ case reports·2026

A novel TAp63γ-Airn regulatory axis governs early myogenic gene networks.

Biology direct·2026

Methodological guidelines for P2X receptor assays and data interpretation.

Cell death & disease·2026

WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma.

Proceedings of the National Academy of Sciences of the United States of America·2026

Elovanoid neuroprotection targets cell transcriptomics and proteomics to sustain synaptic integrity after brain injury.

Communications biology·2026

Langerhans cell histiocytosis: molecular mechanisms underlying pathogenesis and emerging targeted therapeutics.

Cancer metastasis reviews·2026

Mechanical memory as a metastatic compass: a comparative framework for understanding organotropism through biophysical priming.

Cancer metastasis reviews·2026

Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.

Cancer metastasis reviews·2026

Epithelial-mesenchymal transition in carcinoma: navigating phenotypic states to target resistance and metastasis.

Cancer metastasis reviews·2026

Osteomimetic microcalcification shapes the breast tumor microenvironment and metastatic potential.

Cancer metastasis reviews·2026

Three decades of anaplastic lymphoma kinase: from physiological roles to cancer and immune evasion.

Cancer metastasis reviews·2026

A single-center retrospective study evaluating the efficacy of anlotinib plus temozolomide for recurrent glioma based on real-world data.

Translational cancer research·2026

Mechanism of miR-188-5p enhancing radioresistance in nasopharyngeal carcinoma by targeting PTEN to activate the PI3K/Akt signaling pathway.

Translational cancer research·2026

A real-world feasibility and safety study of anlotinib monotherapy in heavily pretreated or temozolomide-ineligible recurrent malignant glioma.

Translational cancer research·2026

Remodeling the tumor immune microenvironment: mechanisms of crosstalk between regulated cell death macrophages.

Frontiers in immunology·2026

Stem cell-derived exosomes preserve diabetic islet function: a systematic review and meta-analysis of preclinical studies.

Biophysics reports·2026

Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances.

American journal of cancer research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us